Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020 | Zendy

Kristina L. Bajema | Zendy; Ryan E. Wiegand | Zendy; Kendra M. Cuffe | Zendy; Sadhna Patel | Zendy; Ronaldo Iachan | Zendy; Travis Lim | Zendy; Adam Lee | Zendy; Davia Moyse | Zendy; Fiona P. Havers | Zendy; Lee E. Harding | Zendy; Alicia M. Fry | Zendy; Aron J. Hall | Zendy; Kelly J. Martin | Zendy; Marjorie Biel | Zendy; Yangyang Deng | Zendy; William A. Meyer | Zendy; Mohit Mathur | Zendy; Tonja M. Kyle | Zendy; Adi V. Gundlapalli | Zendy; Natalie J. Thornburg | Zendy; Lyle R. Petersen | Zendy; Chris Edens | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020

Author(s) -

Kristina L. Bajema,

Ryan E. Wiegand,

Kendra M. Cuffe,

Sadhna Patel,

Ronaldo Iachan,

Travis Lim,

Adam Lee,

Davia Moyse,

Fiona P. Havers,

Lee E. Harding,

Alicia M. Fry,

Aron J. Hall,

Kelly J. Martin,

Marjorie Biel,

Yangyang Deng,

William A. Meyer,

Mohit Mathur,

Tonja M. Kyle,

Adi V. Gundlapalli,

Natalie J. Thornburg,

Lyle R. Petersen,

Chris Edens

Publication year - 2020

Publication title -

jama internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.14

H-Index - 342

eISSN - 2168-6114

pISSN - 2168-6106

DOI - 10.1001/jamainternmed.2020.7976

Subject(s) - seroprevalence , medicine , demography , covid-19 , epidemiology , serology , immunology , antibody , disease , infectious disease (medical specialty) , sociology

Case-based surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection likely underestimates the true prevalence of infections. Large-scale seroprevalence surveys can better estimate infection across many geographic regions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research